


Defying federal 34OB program rules designed to keep medicine affordable for vulnerable communities.
This isn’t just a legal dispute. It’s about access, fairness, and accountability.
340B helps safety-net providers keep medicine and care within reach. When Amgen claws back resources, clinics lose support and patients lose access.
Amgen’s record, the clinics at risk, and the number of patients who could be affected all point to the same thing: this fight is urgent.
The facts, legal context, and real-world stakes behind Amgen’s attack on 340B and the clinics that depend on it.
Stay updated as the case unfolds and new evidence is released.